Humana Inc. (NYSE:HUM) Shares Sold by Gateway Investment Advisers LLC

Gateway Investment Advisers LLC decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 24.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,366 shares of the insurance provider’s stock after selling 746 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Humana were worth $600,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of HUM. Creative Financial Designs Inc. ADV boosted its position in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the period. Atwood & Palmer Inc. bought a new stake in Humana in the third quarter valued at $29,000. Ashton Thomas Securities LLC acquired a new position in shares of Humana during the third quarter valued at $31,000. Your Advocates Ltd. LLP grew its position in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares during the last quarter. Finally, Hollencrest Capital Management acquired a new stake in shares of Humana in the 2nd quarter worth about $40,000. Institutional investors own 92.38% of the company’s stock.

Humana Stock Up 2.5 %

Shares of HUM stock opened at $282.63 on Friday. The stock has a market cap of $34.03 billion, a P/E ratio of 25.03, a price-to-earnings-growth ratio of 2.02 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a fifty day moving average price of $273.81 and a 200 day moving average price of $308.04. Humana Inc. has a one year low of $213.31 and a one year high of $415.73.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Analysts predict that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.25%. Humana’s payout ratio is 31.36%.

Analyst Ratings Changes

Several research firms have commented on HUM. Truist Financial upped their target price on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Wells Fargo & Company dropped their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. TD Cowen raised their price objective on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Finally, Stephens reaffirmed an “equal weight” rating and issued a $250.00 target price on shares of Humana in a research report on Wednesday, October 9th. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $302.70.

Insider Transactions at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.29% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.